150 related articles for article (PubMed ID: 35716322)
1. Inhibition of noncaspase proteases, calpain and proteasome, via ALLN and Bortezomib contributes to cell death through low degradation of pro-/anti-apoptotic proteins and apoptosis induction.
Hamidi R; Ataei F; Hosseinkhani S
Med Oncol; 2022 Jun; 39(9):125. PubMed ID: 35716322
[TBL] [Abstract][Full Text] [Related]
2. Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.
Llobet D; Eritja N; Encinas M; Sorolla A; Yeramian A; Schoenenberger JA; Llombart-Cussac A; Marti RM; Matias-Guiu X; Dolcet X
Anticancer Drugs; 2008 Feb; 19(2):115-24. PubMed ID: 18176107
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death.
Suzuki Y; Nakabayashi Y; Takahashi R
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8662-7. PubMed ID: 11447297
[TBL] [Abstract][Full Text] [Related]
4. Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells.
Singh V; Sharma V; Verma V; Pandey D; Yadav SK; Maikhuri JP; Gupta G
Eur J Nutr; 2015 Dec; 54(8):1255-67. PubMed ID: 25408199
[TBL] [Abstract][Full Text] [Related]
5. A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line.
Yerlikaya A; Okur E; Baykal AT; Acılan C; Boyacı I; Ulukaya E
J Proteomics; 2015 Jan; 113():315-25. PubMed ID: 25305590
[TBL] [Abstract][Full Text] [Related]
6. Calpain-mediated processing of p53-associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking.
Woo MG; Xue K; Liu J; McBride H; Tsang BK
J Biol Chem; 2012 Feb; 287(6):3963-75. PubMed ID: 22117079
[TBL] [Abstract][Full Text] [Related]
7. The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib.
Yerlikaya A; Okur E; Ulukaya E
Tumour Biol; 2012 Oct; 33(5):1385-92. PubMed ID: 22477712
[TBL] [Abstract][Full Text] [Related]
8. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.
Zhu H; Zhang L; Dong F; Guo W; Wu S; Teraishi F; Davis JJ; Chiao PJ; Fang B
Oncogene; 2005 Jul; 24(31):4993-9. PubMed ID: 15824729
[TBL] [Abstract][Full Text] [Related]
9. Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel.
Mehdizadeh K; Ataei F; Hosseinkhani S
Med Oncol; 2021 Apr; 38(6):64. PubMed ID: 33904968
[TBL] [Abstract][Full Text] [Related]
10. The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells.
Kabore AF; Sun J; Hu X; McCrea K; Johnston JB; Gibson SB
Apoptosis; 2006 Jul; 11(7):1175-93. PubMed ID: 16699949
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the ubiquitin-proteasome system sensitizes TRAIL-resistant prostate cancer cells by up-regulation of death receptor 5.
Lee YJ; Seol JW; Jeong JK; Moon MH; Park SY
Mol Med Rep; 2011; 4(6):1255-9. PubMed ID: 21850375
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation.
Li C; Chen S; Yue P; Deng X; Lonial S; Khuri FR; Sun SY
J Biol Chem; 2010 May; 285(21):16096-104. PubMed ID: 20335171
[TBL] [Abstract][Full Text] [Related]
13. Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors.
Zhou W; Hu J; Tang H; Wang D; Huang X; He C; Zhu H
BMC Cancer; 2011 Nov; 11():485. PubMed ID: 22078414
[TBL] [Abstract][Full Text] [Related]
14. Proteasome Stress Triggers Death of SH-SY5Y and T98G Cells via Different Cellular Mechanisms.
Pilchova I; Klacanova K; Dibdiakova K; Saksonova S; Stefanikova A; Vidomanova E; Lichardusova L; Hatok J; Racay P
Neurochem Res; 2017 Nov; 42(11):3170-3185. PubMed ID: 28725954
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode.
Gillissen B; Richter A; Richter A; Overkamp T; Essmann F; Hemmati PG; Preissner R; Belka C; Daniel PT
Cell Death Dis; 2013 May; 4(5):e643. PubMed ID: 23703388
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8.
Laussmann MA; Passante E; Düssmann H; Rauen JA; Würstle ML; Delgado ME; Devocelle M; Prehn JH; Rehm M
Cell Death Differ; 2011 Oct; 18(10):1584-97. PubMed ID: 21455219
[TBL] [Abstract][Full Text] [Related]
17. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition.
An WG; Hwang SG; Trepel JB; Blagosklonny MV
Leukemia; 2000 Jul; 14(7):1276-83. PubMed ID: 10914553
[TBL] [Abstract][Full Text] [Related]
18. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro.
MacFarlane M; Merrison W; Bratton SB; Cohen GM
J Biol Chem; 2002 Sep; 277(39):36611-6. PubMed ID: 12121969
[TBL] [Abstract][Full Text] [Related]
19. Degraded collagen induces calpain-mediated apoptosis and destruction of the X-chromosome-linked inhibitor of apoptosis (xIAP) in human vascular smooth muscle cells.
von Wnuck Lipinski K; Keul P; Lucke S; Heusch G; Wohlschlaeger J; Baba HA; Levkau B
Cardiovasc Res; 2006 Feb; 69(3):697-705. PubMed ID: 16223472
[TBL] [Abstract][Full Text] [Related]
20. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Le Clorennec C; Lazrek Y; Dubreuil O; Sampaio C; Larbouret C; Lanotte R; Poul MA; Barret JM; Prost JF; Pèlegrin A; Chardès T
Cell Commun Signal; 2019 Aug; 17(1):106. PubMed ID: 31443721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
